SI-BONE (SIBN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
21 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, at 8:00 a.m. Pacific Time, with virtual attendance available.
Shareholders are encouraged to review proxy materials and vote by June 3, 2026, 8:59 p.m. Pacific Time.
Voting matters and shareholder proposals
Election of two directors: Jeffrey W. Dunn and John G. Freund, M.D., both recommended by the board.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (Say-on-Pay) included.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends all proposals, including director nominees and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from SI-BONE
- Q1 2026 saw 11.2% revenue growth, margin strength, and raised full-year guidance.SIBN
Q1 202611 May 2026 - Double-digit growth, record profitability, and innovation drive expansion in a $3.5B+ market.SIBN
Corporate presentation11 May 2026 - Strong revenue growth, improved profitability, and robust governance mark this year's proxy.SIBN
Proxy filing22 Apr 2026 - Strategic innovation and partnerships drive growth and market expansion through 2028.SIBN
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - 20% revenue growth and positive adjusted EBITDA in 2025; strong 2026 outlook ahead.SIBN
Q4 202523 Feb 2026 - Market leader in sacropelvic devices, accelerating growth with new launches and nearing profitability.SIBN
2024 Truist Securities MedTech Conference3 Feb 2026 - Q2 2024 revenue up 20%, net loss narrows, 2024 guidance raised, and positive EBITDA expected.SIBN
Q2 20242 Feb 2026 - Record growth, product innovation, and salesforce gains set the stage for profitability in 2024.SIBN
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - New product launches and platform expansion drive growth and profitability targets for 2025.SIBN
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026